Lv72
4300 积分 2021-05-06 加入
Discovery of BMS-159, an Orally Active Imidazotriazine Pan-CK2 Inhibitor for the Treatment of Cancer
1天前
待确认
Discovery of MK-5661, a Once-Daily Oral Na V 1.8 Inhibitor for the Treatment of Pain
1天前
待确认
Exatecan Payload-Based Antibody-Drug Conjugates with a Short Hydrophilic Cleavable Linker
1天前
待确认
Re-Evaluating Antibody–Drug Conjugate Linker Stability: Assessment, Interpretation, and Clinical Translation
3天前
已完结
Transglutaminase-Based Chemo-Enzymatic Conjugation Approach Yields Homogeneous Antibody–Drug Conjugates
13天前
已完结
Immune mediated inflammatory disease: T cell engager versus antibody drug conjugate
17天前
已完结
Multivalent linkers: A growing trend in antibody–drug conjugate development
17天前
已完结
Polyethylene glycol-based linkers as hydrophilicity reservoir for antibody-drug conjugates
20天前
已完结
Next generation antibody drugs: pursuit of the 'high-hanging fruit'
20天前
已完结
The role of hydrophilic linkers in next-generation antibody-drug conjugates
20天前
已完结
皖公网安备34019202002308